FREE Case Review (866) 588-0600

Alabama Risperdal Lawsuit

A lawsuit filed by a 20-year-old Alabama man alleges that the antipsychotic drug Risperdal can cause gynecomastia, a medical condition characterized by abnormal breast growth in boys and young men.

A lawsuit filed by a 20-year-old Alabama man in the Philadelphia County Court of Common Pleas alleges that the antipsychotic drug Risperdal (risperidone) can cause gynecomastia, a medical condition characterized by abnormal breast growth in boys and young men. The complaint alleges that Janssen Pharmaceuticals and parent company Johnson & Johnson knew about the gynecomastia risk associated with Risperdal, but failed to adequately warn the public and medical communities about it.

Free Risperdal Lawsuit Evaluation: If you or a loved one has been injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Risperdal and we can help.

What’s the Problem?

According to the lawsuit, the plaintiff was 8 years old when he was prescribed Risperdal for the treatment of autism. The antipsychotic caused him to develop large, female-like breasts that later had to be removed through a double mastectomy, the complaint alleges.

Risperdal had not been approved to treat autism in pediatric patients at the time the plaintiff began taking the drug, according to the suit. Prescribing a drug for an unapproved purpose is considered “off-label,” and is done at the doctor’s discretion; however, it is illegal for drug makers to promote their products for off-label use.

The complaint alleges that Janssen marketed Risperdal off-label, and never warned that the drug could increase prolactin levels, which stimulates male breast growth. Additionally, the suit alleges that Janssen engineered studies to make Risperdal appear safer and more effective than it actually is.

Janssen argued that Risperdal labels include information about increased prolactin levels and a reference to gynecomastia; plaintiffs countered that the labeling was insufficient. Janssen further claimed that the risk of gynecomastia was 1 in 1,000; however, plaintiffs argue that the actual risk is 3 or 4 out of 100. An internal study conducted by the company allegedly found increased prolactin levels in 87% of children who had taken Risperdal.

There are currently more than 700 state and federal Risperdal gynecomastia lawsuits pending in: In Re: Risperdal Litigation, Case Number 100300296.

Do I Have a Risperdal Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Risperdal lawsuits. We are handling individual litigation nationwide and currently accepting new Risperdal injury cases in all 50 states.

Free Risperdal Lawsuit Evaluation: If you or a loved one has been injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a Risperdal injury suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition